Wednesday, November 18, 2009 2:57:57 PM
07/27/2007 09:47:07 Sold 400 GENX @ 0.47 182.99 ---
08/06/2007 14:34:54 Sold 500 GENX @ 0.465 227.49 ---
08/07/2007 13:11:55 Sold 800 GENX @ 0.465 366.99 ---
08/13/2007 12:12:27 Sold 3300 GENX @ 0.45 1,479.97 ---
Page:
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM